Sharon Bio-Medicine completes expansion of mfg facilities

Sharon Bio-Medicine has completed expansion of its three manufacturing facilities. According to a statement issued by the company to the exchanges, it invested about ₹125 crore for the expansion. Of this, ₹85 crore was spent on the Dehradun formulations plant. Capacity at the plant has been more than doubled. Commercial production is expected to kick off in June. At Sharon’s two other expanded plants at Taloja near Navi Mumbai, commercial production has already started. After hitting ₹43.3 in early trade, the stock closed flat at ₹41.95 on Wednesday.